Business & Regulation

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

Sitting Down With… Gen Li, CEO, Phesi

A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?

Can AI realistically transform data management in pharma? Yes. And it’s already begun.

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?

What did switching from client to constructor teach a seasoned biotech professional?

Fake tweet announcing free insulin leads to mayhem.

How a new working group plans to overcome the problem with in vitro pharmacology data.

Unregulated drugs being sold and distributed by the online retailer come under fire.

Substandard and falsified medicines are a global threat, but a collective pushback can beat them